Skip to main content

Table 2 Mean of three distances (mm) measured over the swelling using Laskin method (mean ± SEM)

From: Efficacy of serratiopeptidase after impacted third molar surgery: a randomized controlled clinical trial

Groups

Preoperative (Day 0)

Postoperative (Day 4)

(Day 5)

DHC

   

 Test

108.41 ± 8.6

111.49 ± 8.1***

109.29 ± 8.2***

 Control

109.98 ± 9.7

115.39 ± 9.9***

114.01 ± 9.8***

 Effect size (d)

0.67

1.07

 

DHS

   

 Test

147.14 ± 10.2

150.76 ± 9.1**

148.1 ± 9.1***

 Control

146.01 ± 13.6

151.12 ± 14.2**

150.1 ± 14.1***

 Effect size (d)

0.45

0.97

 

DV

   

 Test

104.26 ± 13.4

106.17 ± 13.7***104.73 ± 13.5***

 

 Control

103.98 ± 9.9

107.42 ± 9.7***

106.19 ± 9.7***

 Effect size (d)

0.69

0.98

 
  1. Significance of treatment group in comparison with placebo on respective days
  2. **p < 0.01; ***p < 0.001